A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial ...
Mar 10, 2013
0
0
Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not have blocked arteries often experience changes in their symptoms and stress test results over time, according to research ...
Mar 30, 2020
0
6
(HealthDay) -- Cardiac shock wave therapy (CSWT) can significantly improve symptoms, ischemic threshold during exercise, and specific quality-of-life parameters for patients with chronic refractory angina pectoris, according ...
Mar 30, 2012
0
0
Generic anti-platelet drugs seem to work as well as a brand name drug for heart patients, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Mar 13, 2018
0
23
Among patients with acute coronary syndromes (such as heart attack or unstable angina) treated at public hospitals in Brazil, implementation of a multifaceted intervention that included educational materials, checklists and ...
Mar 25, 2012
0
0
A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34—a ...
Jun 1, 2016
0
1
A true obesity epidemic is gradually advancing throughout the developed world. A large new Danish-British study from the University of Copenhagen and University of Bristol documents for the first time a definite correlation ...
May 1, 2012
0
0
That feeling of crushing pain in your chest can be a medical emergency, but it can also be angina pectoris, or "stable angina"—a symptom of coronary heart disease that can be managed with medication.
Feb 7, 2023
0
5
The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the ...
Aug 27, 2012
0
0
Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor (VEGF) gene therapy treatment for patients who have advanced coronary artery disease (CAD). The late-breaking ...
May 2, 2024
0
0
